ALK is a transmembrane receptor tyrosine kinase (RTK) belonging to the insulin receptor superfamily [176], whose deregulation is involved in the carcinogenesis process of various human malignancies, including NB [177]. This evidence concerns the gene ALK and neuroblastoma.